GAL (released from nerves) exerted a nerve–tumor crosstalk by activating GAL2R expressed in tumor cells and by inducing NFATC2-mediated transcription of cyclooxygenase-2 and GAL; then, GAL released from tumor cells promoted neuritogenesis, favoring PNI [84]. The gene discussed is PTGS2; the disease is neoplasm.